The effect of excessive fat tissue on the measure of bone mineral density by dual X-ray absorptiometry: the impact of substantial weight loss following sleeve gastrectomy.
Absorptiometry, Photon
Adipose Tissue
/ diagnostic imaging
Adiposity
Adolescent
Adult
Aged
Bone Density
Bone and Bones
/ diagnostic imaging
Female
Gastrectomy
Humans
Male
Middle Aged
Obesity
/ diagnostic imaging
Predictive Value of Tests
Reproducibility of Results
Time Factors
Treatment Outcome
Weight Loss
Young Adult
bone mineral density
dual-energy X-ray absorptiometry
fat mass
obese
overweight
underestimation
Journal
Clinical physiology and functional imaging
ISSN: 1475-097X
Titre abrégé: Clin Physiol Funct Imaging
Pays: England
ID NLM: 101137604
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
23
11
2018
accepted:
11
05
2019
pubmed:
16
5
2019
medline:
6
2
2020
entrez:
16
5
2019
Statut:
ppublish
Résumé
Dual-energy X-ray absorptiometry (DXA) is used in clinical routine to determine areal bone mineral density (aBMD). However, it is not clear whether excessive fat mass or substantial weight loss modify the aBMD measurements. The aim of this study was to evaluate the effect of soft tissue composition on aBMD measured by DXA using a clinical model (i.e. sleeve gastrectomy: SG) that induces substantial body weight loss. Areal bone mineral density and body composition (fat mass: FM and lean tissue mass: LTM) were determined by DXA in 41 obese patients (33 women, 80.5%) just before SG and 1 month later. One month after SG, mean weight loss was -9.8 ± 2.6 kg, with a significant decrease in LTM and FM (kg) ranging from -7.3% to -9.5%. The relative variation in aBMD was increased at the lumbar spine (2.45 ± 3.44%) and decreased at the hip (-1.47 ± 2.28%), whereas no variation was observed for the whole body and radius. The variation in aBMD at the lumbar spine was inversely correlated with variations in weight, whole-body FM and trunk FM, but not LTM. This study shows evidence of a potential effect of body composition, particularly FM, on aBMD. However, given the modest change in aBMD, which was close to the precision error of aBMD measurements, it appears that significant weight loss does not have a clinically significant impact on the evaluation of aBMD using DXA.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
345-354Informations de copyright
© 2019 Scandinavian Society of Clinical Physiology and Nuclear Medicine. Published by John Wiley & Sons Ltd.